A new vaccine to protect against Respiratory Syncytial Virus (RSV) is now being introduced.
Individuals who turn 75 on or after 1 September 2024 will be eligible for a one-time RSV vaccination, as older adults are at greater risk of developing severe complications from the virus.
We have begun contacting eligible patients with invitations to receive the vaccine. More information about RSV and the vaccination can be found using the link below.

